Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.82 |
| ▸ | HPGD | P15428 | 1/20 | 0.82 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.54 |
| ▸ | POLB | P06746 | 3/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | CDC25B | P30305 | 2/20 | 0.52 |
| ▸ | CDC25A | P30304 | 1/20 | 0.52 |
| ▸ | CDC25C | P30307 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL283472 | 0.90 | ALDH1A1 (1.00) | ALDH1A1HPGDKDM4EPOLBGLA | |
| SCHEMBL9443224 | 0.84 | ALDH1A1 (0.86) | ALDH1A1HPGDKDM4EPOLBGLA | |
| SCHEMBL7916743 | 0.81 | ALDH1A1 (0.81) | ALDH1A1HPGDKDM4EPOLBGLA | |
| SCHEMBL20702693 | 0.81 | ALDH1A1 (0.81) | ALDH1A1HPGDKDM4EPOLBCDC25B | |
| SCHEMBL9271743 | 0.81 | ALDH1A1 (0.67) | ALDH1A1HPGDKDM4EPOLBLMNA | |
| Acrylic Acid Ethyl Ester SCHEMBL28809731 | 0.81 | ALDH1A1 (0.63) | ALDH1A1HPGDKDM4EPOLBCDC25B | |
| SCHEMBL10959203 | 0.79 | HPGD (0.78) | ALDH1A1HPGDKDM4EPOLBCDC25B | |
| SCHEMBL11766437 | 0.79 | ALDH1A1 (0.77) | ALDH1A1HPGDKDM4EPOLBGLA | |
| Ethyl Phenylcarbamate SCHEMBL19712998 | 0.79 | RAB9A (0.63) | ALDH1A1HPGDKDM4EPOLBGLA | |
| SCHEMBL734966 | 0.79 | ALDH1A1 (0.72) | ALDH1A1HPGDKDM4EPOLBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107001246-B | Naphthyl acrylates as writing monomers for photopolymers | 科思创德国股份有限公司 | 2021-02-02 | — | — | CN | disclosed |
| US-10241402-B2 | Naphthyl acrylates as writing monomers for photopolymers | COVESTRO DEUTSCHLAND AG (DE) | 2019-03-26 | — | — | US | disclosed |
| US-20170363957-A1 | NAPHTHYL ACRYLATES AS WRITING MONOMERS FOR PHOTOPOLYMERS | COVESTRO DEUTSCHLAND AG (DE) | 2017-12-21 | — | — | US | disclosed |
| EP-3230261-A1 | NAPHTHYL ACRYLATES AS WRITING MONOMERS FOR PHOTOPOLYMERS | Covestro Deutschland AG (DE) | 2017-10-18 | — | — | EP | disclosed |
| WO-2016091965-A1 | NAPHTHYL ACRYLATES AS WRITING MONOMERS FOR PHOTOPOLYMERS | COVESTRO DEUTSCHLAND AG (DE) | 2016-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170363957-A1 | NAPHTHYL ACRYLATES AS WRITING MONOMERS FOR PHOTOPOLYMERS | NEFM, ACR, DIAPH1 | ALDH1A1 1558/4885HPGD 18/4885KDM4E 1621/4885 |
| US-10241402-B2 | Naphthyl acrylates as writing monomers for photopolymers | NEFM, ACR, DIAPH1 | ALDH1A1 1558/4885HPGD 18/4885KDM4E 1621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.